Cholecystokinin-induced hypophagia is not potentiated by cancer anorexia.
The interaction of cholecystokinin-induced hypophagia with cancer anorexia was investigated within both acute (Walker 256 carcinosarcoma) and chronic (methylcholanthrene-induced sarcoma) animal models of cancer anorexia. Cholecystokinin octapeptide (CCK8) effectively reduced feeding for at least one hour in both groups of rats. However, this peptide was no more effective in inducing hypophagia in tumor-bearing rats than in nontumor-bearing control rats when tested at a variety of doses (0.5, 5.0 and 50.0 microgram/kg; IP) both prior to and after the development of anorexia. Therefore, these data do not support a role of cholecystokinin in the mediation of experimental cancer anorexia, since no synergism of CCK8-induced hypophagia with the anorexia was observed.
D000818:Animals; D000855:Anorexia / Q000150:complications / Q000503:physiopathology*; D001066:Appetite / Q000187:drug effects; D001835:Body Weight; D002279:Carcinoma 256, Walker / Q000150:complications / Q000503:physiopathology*; D003680:Deglutition Disorders / Q000139:chemically induced* / Q000150:complications; D005247:Feeding Behavior / Q000187:drug effects; D001068:Feeding and Eating Disorders / Q000503:physiopathology*; D005260:Female; D005508:Food Deprivation; D006801:Humans; D051381:Rats; D011919:Rats, Inbred Strains; D012844:Sincalide / Q000633:toxicity*; D013997:Time Factors
D012844:Sincalide